- Home
- GMED vs ASND Comparison
GMED vs ASND Comparison
Compare GMED & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- ASND
- Stock Information
- Founded
- GMED 2003
- ASND 2006
- Country
- GMED United States
- ASND Denmark
- Employees
- GMED N/A
- ASND N/A
- Industry
- GMED Medical/Dental Instruments
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- GMED Health Care
- ASND Health Care
- Exchange
- GMED Nasdaq
- ASND Nasdaq
- Market Cap
- GMED 9.6B
- ASND 9.1B
- IPO Year
- GMED 2012
- ASND 2015
- Fundamental
- Price
- GMED $72.50
- ASND $159.39
- Analyst Decision
- GMED Buy
- ASND Strong Buy
- Analyst Count
- GMED 13
- ASND 16
- Target Price
- GMED $96.91
- ASND $213.88
- AVG Volume (30 Days)
- GMED 994.2K
- ASND 587.4K
- Earning Date
- GMED 05-08-2025
- ASND 05-01-2025
- Dividend Yield
- GMED N/A
- ASND N/A
- EPS Growth
- GMED N/A
- ASND N/A
- EPS
- GMED 0.75
- ASND N/A
- Revenue
- GMED $2,519,355,000.00
- ASND $398,509,511.00
- Revenue This Year
- GMED $9.12
- ASND $62.61
- Revenue Next Year
- GMED $6.91
- ASND $72.16
- P/E Ratio
- GMED $96.61
- ASND N/A
- Revenue Growth
- GMED 60.62
- ASND 12.06
- 52 Week Low
- GMED $49.33
- ASND $111.09
- 52 Week High
- GMED $94.93
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- GMED 50.87
- ASND 49.26
- Support Level
- GMED $69.72
- ASND $164.24
- Resistance Level
- GMED $72.61
- ASND $183.00
- Average True Range (ATR)
- GMED 1.68
- ASND 7.80
- MACD
- GMED 0.20
- ASND -0.49
- Stochastic Oscillator
- GMED 69.00
- ASND 20.85
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.